BioSpace News Archive

Pacific Neuroscience Institute, in collaboration with John Wayne Cancer Institute at Providence Saint John’s Health Center, is very pleased to announce the opening of its new Multidisciplinary Neuroanatomy and Surgical Skills Laboratory located at John Wayne Cancer Institute.

Evolus, Inc. (NASDAQ: EOLS), a performance beauty company with a customer-centric approach focused on delivering breakthrough products, today announced that management will be participating in the Barclays 2020 Global Healthcare Conference in Miami, Florida.

Rafael Pharmaceuticals, Inc. (“Rafael” or the “Company”), a leader in the growing field of cancer metabolism-based therapeutics, today announced the appointment of Sanjay Sehgal, Ph.D., to Chief Regulatory Affairs and Quality Assurance Officer.

Neovasc Inc. (“Neovasc” or the “Company”) (NASDAQ, TSX: NVCN), a leader in the development of minimally invasive transcatheter mitral valve replacement technologies and minimally invasive devices for the treatment of refractory angina, announced today the Neovasc Reducer™ (the “Reducer”) was featured in the peer reviewed publication EuroIntervention, the official Journal of EuroPCR and the European Association of Percutaneous Cardiovascular Interventions (EAPCI) and highlighted in PCR Online.

Kannalife, Inc. (“Kannalife” or the “Company”) (OTCQB: KLFE), a biopharmaceutical med-chem company specializing in the research and development of novel monotherapeutics, announced today that the European Patent Office has issued the Company, European Patent EP3094318B1 (the “Patent”) specific to “Novel Functionalized 1,3-Benzene Diols and their Method of Use for the Treatment of Hepatic Encephalopathy.

twoXAR Pharmaceuticals, a company that discovers drugs with AI, today announced the appointment of Mark Eller, Ph.D. as the Senior Vice President of Research and Development and Anjali Pandey, Ph.D. as the Senior Vice President of Nonclinical R&D and Chemistry. Both Dr. Eller and Dr. Pandey will report directly to Andrew A. Radin, CEO at twoXAR, and immediately assume direct responsibility for advancing 18 R&D programs across multiple therapeutic areas.

Remark Holdings, Inc. (NASDAQ: MARK), a diversified global technology company with leading artificial intelligence (“AI”) solutions and digital media properties, today announced a significant upgrade to its AI-based product offerings.

Innovative Forensic DNA announces the addition of Andrea Noyes to the firm as Investigative Genetic Genealogist and Co-Managing Director

A new survey of hospital C-suite leaders reveals 35% wish they had chosen a different EMR; more than half say they will seek out HIT solutions beyond the EMR for key needs

Sales Readiness Leader Honored for Enabling Businesses to Quickly and Easily Create Learning Content That Drives Sales Effectiveness and Results